Who owns the RARE DISEASE THERAPEUTICS trademark?

The RARE DISEASE THERAPEUTICS trademark is owned by Orphan Pharmaceuticals, U.S.A., Inc..

What is the serial number for RARE DISEASE THERAPEUTICS?

The USPTO serial number for RARE DISEASE THERAPEUTICS is 76196277.

What is the registration number for RARE DISEASE THERAPEUTICS?

RARE DISEASE THERAPEUTICS is registered under USPTO registration number 0.

RAR

USPTO Trademark Record

ABANDONED

RARE DISEASE THERAPEUTICS

Q: What class is the RARE DISEASE THERAPEUTICS trademark registered in?

The RARE DISEASE THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 76196277·Reg 0·Filed Jan 18, 2001

Owner Orphan Pharmaceuticals, U.S.A., Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

RARE DISEASE THERAPEUTICS (Serial No. 76196277), Registration No. 0, is a abandoned US trademark filed on Jan 18, 2001 by Orphan Pharmaceuticals, U.S.A., Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

RARE DISEASE THERAPEUTICS (Reg. #0) is an abandoned US trademark that was filed in 2001 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jan 18, 2001

SERIAL

76196277

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Orphan Pharmaceuticals, U.S.A., Inc.

Entity

Corporation

State

Address

1101 Kermit Dr., Ste 608, Nashville, TN, 37217

Country

Attorney

NameMark J. Patterson

Law firm

MARK J PATTERSON WADDEY & PATTERSON

Docket

N-6833

Address

414 UNION ST STE 2020, BANK OF AMERICA PLZ, NASHVILLE, TN 37219, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateJan 18, 2001

Serial Number76196277

Registration No.0

Registration DateDec 31, 1969

Status DateMar 06, 2003

Mark TypeTypeset (words/letters/numbers)

Attorney DocketN-6833

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2001

YEARS AGO

25y

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

8 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Mar 06, 2003

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ASSIGNED TO EXAMINER

Oct 11, 2002

ASSIGNED TO EXAMINER

FINAL REFUSAL MAILED

Jun 27, 2002

FINAL REFUSAL MAILED

ASSIGNED TO EXAMINER

Feb 25, 2002

ASSIGNED TO EXAMINER

Jan 30, 2002

ASSIGNED TO EXAMINER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 19, 2001

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION MAILED

May 17, 2001

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

May 02, 2001

ASSIGNED TO EXAMINER

RARE DISEASE THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Orphan Pharmaceuticals, U.S.A., Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Mark J. Patterson

Resources

Company